Javascript must be enabled to continue!
Activation of the Alternative Complement Pathway by Escherichia Coli: Resistance of Bound C3b to Inactivation by C3bINA and β1H
View through CrossRef
Abstract
The surfaces of activators of the alternative pathway, such as zymosan and rabbit erythrocytes, provide sites which protect bound C3b from inactivation by C3b inactivator (C3bINA) and β1H, and P,C3b,Bb from decay-dissociation by β1H. This circumstance permits surface-associated amplified generation and deposition of C3b. The capacity of a bacterial surface, if analogous to zymosan and rabbit erythrocytes, to protect and thereby accumulate increasing amounts of C3b by local circumvention of the regulatory proteins would be compatible with a unique role of the alternative pathway in host defense. The susceptibility of C3b bound to Escherichia coli to C3bINA was compared with that of C3b bound to the nonactivator, sheep erythrocytes, in the state, EAC4b,3b. E. coli W3110, killed by heating at 60°C for 60 min, activated the alternative pathway in human serum diluted 1:5 in GVB containing 2 mM Mg++ and 8 mM EGTA as demonstrated by 82% C3 and 87% B consumption. The killed E. coli were coated with C3b by incubation with purified C3, B and D, washed in GVB containing 0.04 M EDTA (GVB-EDTA) and resuspended in GVB with 0.15 mM Ca++ and 0.5 M Mg++ (GVB++). The dose responses of particle-bound C3b were established by incubating dilutions of EAC4b,3b and E. coli-C3b, respectively, with B and D in GVB++ for 60 min at 37°C, followed by centrifugation and hemolytic assay of residual fluid phase B. The relative susceptibilities of C3b bound to sheep erythrocytes and E. coli to inactivation by purified C3MNA in the presence of β1H were studied in a time-dependent fashion with amounts of particle-bound C3b that gave comparable inactivation of B by D. The purified control proteins inactivated 76% C3b on EAC4b,3b in 60 min at 37°C but reduced C3b activity on E. coli by only 10%. Similarly, when human serum diluted in GVB-EDTA was used as the source of control proteins, 96% of C3b activity on sheep erythrocytes was abolished in 60 min, whereas only 18% of C3b on E. coli was inactivated in the same time interval. Thus, the surface of E. coli, like that of two other activators of the alternative pathway, zymosan and rabbit erythrocytes, protects bound C3b from inactivation and promotes alternative pathway-dependent opsonic recognition.
Title: Activation of the Alternative Complement Pathway by Escherichia Coli: Resistance of Bound C3b to Inactivation by C3bINA and β1H
Description:
Abstract
The surfaces of activators of the alternative pathway, such as zymosan and rabbit erythrocytes, provide sites which protect bound C3b from inactivation by C3b inactivator (C3bINA) and β1H, and P,C3b,Bb from decay-dissociation by β1H.
This circumstance permits surface-associated amplified generation and deposition of C3b.
The capacity of a bacterial surface, if analogous to zymosan and rabbit erythrocytes, to protect and thereby accumulate increasing amounts of C3b by local circumvention of the regulatory proteins would be compatible with a unique role of the alternative pathway in host defense.
The susceptibility of C3b bound to Escherichia coli to C3bINA was compared with that of C3b bound to the nonactivator, sheep erythrocytes, in the state, EAC4b,3b.
E.
coli W3110, killed by heating at 60°C for 60 min, activated the alternative pathway in human serum diluted 1:5 in GVB containing 2 mM Mg++ and 8 mM EGTA as demonstrated by 82% C3 and 87% B consumption.
The killed E.
coli were coated with C3b by incubation with purified C3, B and D, washed in GVB containing 0.
04 M EDTA (GVB-EDTA) and resuspended in GVB with 0.
15 mM Ca++ and 0.
5 M Mg++ (GVB++).
The dose responses of particle-bound C3b were established by incubating dilutions of EAC4b,3b and E.
coli-C3b, respectively, with B and D in GVB++ for 60 min at 37°C, followed by centrifugation and hemolytic assay of residual fluid phase B.
The relative susceptibilities of C3b bound to sheep erythrocytes and E.
coli to inactivation by purified C3MNA in the presence of β1H were studied in a time-dependent fashion with amounts of particle-bound C3b that gave comparable inactivation of B by D.
The purified control proteins inactivated 76% C3b on EAC4b,3b in 60 min at 37°C but reduced C3b activity on E.
coli by only 10%.
Similarly, when human serum diluted in GVB-EDTA was used as the source of control proteins, 96% of C3b activity on sheep erythrocytes was abolished in 60 min, whereas only 18% of C3b on E.
coli was inactivated in the same time interval.
Thus, the surface of E.
coli, like that of two other activators of the alternative pathway, zymosan and rabbit erythrocytes, protects bound C3b from inactivation and promotes alternative pathway-dependent opsonic recognition.
Related Results
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract
Introduction
Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
The Physiological Breakdown of C3b
The Physiological Breakdown of C3b
Abstract
The requirements for and products of C3b inactivator (KAF) action on C3b have been studied. C3 was purified from human serum. Final traces of contaminating ...
Inhibition of the Complement Alternative Pathway Attenuates Hemolysis and Preserves Renal Function in a Mouse Model of Sickle Cell Disease
Inhibition of the Complement Alternative Pathway Attenuates Hemolysis and Preserves Renal Function in a Mouse Model of Sickle Cell Disease
Introduction: the alternative pathway (AP) of complement activation plays a significant role in the pathophysiology of sickle cell disease (SCD), contributing to hemolysis and subs...
Complement Activation and Its Implication in the Pathophysiology of Hemolytic Anemia and Aging in Mouse Models of Sickle Cell Disease and Beta-Thalassemia
Complement Activation and Its Implication in the Pathophysiology of Hemolytic Anemia and Aging in Mouse Models of Sickle Cell Disease and Beta-Thalassemia
Introduction: complement activation plays a crucial role in the immune response and has been increasingly recognized for its involvement in various hemolytic anemias. In sickle cel...
Modulation of Macrophage C3b Receptor Function by Cytochalasin-Sensitive Structures
Modulation of Macrophage C3b Receptor Function by Cytochalasin-Sensitive Structures
Abstract
A quantitative rosette assay was employed in order to determine if through pharmacologic probes we could gain an insight into the nature of the interaction ...
Molecular Mechanisms of Target Recognition in an Innate Immune System: Interactions Among Factor H, C3b, and Target in the Alternative Pathway of Human Complement
Molecular Mechanisms of Target Recognition in an Innate Immune System: Interactions Among Factor H, C3b, and Target in the Alternative Pathway of Human Complement
AbstractIn the alternative pathway of complement (APC) factor H is the primary control factor involved in discrimination between potential pathogens. The APC deposits C3b on possib...
TRANSFORMASI PLASMID YANG MENGANDUNG GEN merB PADA Escherichia coli BL21(DE3)
TRANSFORMASI PLASMID YANG MENGANDUNG GEN merB PADA Escherichia coli BL21(DE3)
ABSTRACTDNA transformation is one of the methods for inserting DNA into bacterial cells. The current transformation method is widely used to transfer plasmids containing genetic ma...
Multidrug resistance, biofilm formation, and virulence genes of Escherichia coli from backyard poultry farms
Multidrug resistance, biofilm formation, and virulence genes of Escherichia coli from backyard poultry farms
Background and Aim: Backyard chicken flocks have traditionally been regarded as an essential food source in developed countries; however, they may act as reservoirs and spread vari...

